Samsung Bioepis to file ‘Humira’ patent nullification lawsuit
Samsung Bioepis filed a lawsuit to nullify a patent against a global pharmaceutical company Abbvie in the U.K.
The reason for the lawsuit is that Abbvie encountering the patent expiration of ‘Humira,’ a rheumatoid arthritis therapy, is blocking entry of other drugs into the market. The day the l...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
